IP Library Granted Patent US 9,526,738
Granted Patent B2
US 9,526,738 · App. 13/256,928 · Granted Dec 27, 2016

Topical gels and methods of using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,526,738
App. No.
13/256,928
Granted
Dec 27, 2016
Kind
B2
Abstract

Provided according to some embodiments of the invention are topical gels that may release nitric oxide. Also provided are methods of using such topical gels in the treatment of wounds and other skin ailments. The topical gels comprise diazeniutndiolate-functionalized polysiloxane macromolecules.

Claims (31)

1. A topical composition comprising nitric oxide-releasing polysiloxane macromolecules and a hydrophobic, non-aqueous gel base, the hydrophobic, non-aqueous gel base comprising mineral oil, wherein the nitric oxide (NO) storage per gram is in a range of 100 nmol NO/g to 1 mmol NO/g of the topical composition and at least 70% of NO of the nitric oxide-releasing polysiloxane macromolecule remains in the topical composition two days after initial formulation when the topical composition is stored at room temperature.

2. The topical composition of claim 1 , wherein the concentration of the nitric oxide-releasing polysiloxane macromolecules is in a range of 0.1% to 20% by weight of the topical composition.

3. The topical composition of claim 1 , wherein the hydrophobic, non-aqueous gel base is a silicone gel.

4. The topical composition of claim 1 , wherein the hydrophobic, non-aqueous gel base comprises petrolatum.

5. The topical composition of claim 1 , wherein mineral oil is present in the topical composition at a concentration in a range of 10% to 90% by weight of the topical composition.

6. The topical composition of claim 1 , wherein the hydrophobic, non-aqueous gel base comprises gel excipients and the nitric oxide-releasing polysiloxane macromolecules and gel excipients have an octanol/water partition coefficient in a range of 0.1 to 7.

7. The topical composition of claim 1 , wherein the nitric oxide-releasing polysiloxane macromolecules have a hydrodynamic radius in a range of 1000 nm to 10 microns.

8. The topical composition of claim 1 , wherein the nitric oxide-releasing polysiloxane macromolecules have a hydrodynamic radius in a range of 1 nm to 100 nm.

9. The topical composition of claim 1 , further comprising an anti-acne agent, antimicrobial agent, benzoyl peroxide, or a corticosteroid.

10. A topical composition comprising nitric oxide-releasing polysiloxane macromolecules and a hydrophilic gel base, the hydrophilic gel base comprising an alcohol, wherein the nitric oxide (NO) storage per gram is in a range of 100 nmol NO/g to 1 mmol NO/g of the topical composition and at least 70% of NO of the nitric oxide-releasing polysiloxane macromolecule remains in the topical composition two days after initial formulation when the topical composition is stored at room temperature.

11. The topical composition of claim 10 , wherein the concentration of the nitric oxide-releasing polysiloxane macromolecules is in a range of 0.1% to 20% by weight of the topical composition.

12. The topical composition of claim 10 , further comprising isopropyl alcohol at a concentration in a range of 60% to 90% by weight of the topical composition; and hydroxypropyl cellulose at a concentration in a range of 0.75% to 2.5% by weight of the topical composition.

13. The topical composition of claim 10 , wherein the hydrophilic gel base comprises gel excipients and the nitric oxide-releasing polysiloxane macromolecules and the gel excipients have an octanol/water partition coefficient in a range of −2 to 0.

14. The topical composition of claim 10 , wherein the nitric oxide-releasing polysiloxane macromolecules have a hydrodynamic radius in a range of 1000 nm to 10 microns.

15. The topical composition of claim 10 , wherein the nitric oxide-releasing polysiloxane macromolecules have a hydrodynamic radius in a range of 1 nm to 100 nm.

16. The topical composition of claim 10 , further comprising a retinoid, antimicrobial agent, benzoyl peroxide, or a corticosteroid.

17. A method of treating a wound comprising applying the topical composition of claim 1 .

18. A method of treating a wound comprising applying the topical composition of claim 10 .

19. A method of treating a burn comprising applying the topical composition of claim 1 .

20. A method of treating acne comprising applying the topical composition of claim 1 .

21. A method of treating acne comprising applying the topical composition of claim 10 .

22. The topical composition of claim 1 , wherein at least 80% of NO of the nitric oxide-releasing polysiloxane macromolecule remains in the topical composition two days after initial formulation when the topical composition is stored at room temperature.

23. The topical composition of claim 10 , wherein at least 80% of NO of the nitric oxide-releasing polysiloxane macromolecule remains in the topical composition two days after initial formulation when the topical composition is stored at room temperature.

24. The topical composition of claim 1 , wherein the topical composition comprises one or more hydrophobic components and the total concentration of the one or more hydrophobic components present in the topical composition is at least 49% by weight of the topical composition.

25. The topical composition of claim 1 , wherein the topical composition comprises one or more hydrophobic components and the total concentration of the one or more hydrophobic components present in the topical composition is at least 80% by weight of the topical composition.

26. The topical composition of claim 10 , wherein the alcohol is present in the topical composition at a concentration of at least 60% by weight of the topical composition.

27. The topical composition of claim 10 , wherein the alcohol is present in the topical composition at a concentration in a range of 60% to 90% by weight of the topical composition.

28. The topical composition of claim 10 , wherein the alcohol is isopropyl alcohol.

29. The topical composition of claim 10 , wherein the hydrophilic gel base further comprises hydroxypropyl cellulose.

30. The topical composition of claim 29 , wherein the hydroxypropyl cellulose is present at a concentration in a range of 0.75% to 2.5% by weight of the composition.

31. The topical composition of claim 10 , wherein the topical composition is non-aqueous.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2025
From: LNHC, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 071481/0040 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2024
From: NOVAN, INC.
To: LNHC, INC.
Reel/Frame 066350/0942 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2011
From: STASKO, NATHAN; BAUMAN, SUSANNE; JOSHI, PRANAV R.
To: NOVAN, INC.
Reel/Frame 027017/0124 →